Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(299)
•••
Comment by TrendSwapperon Sep 12, 2018 9:19pm
155 Views
Post# 28609339

RE:PLACE YOUR BETS!

RE:PLACE YOUR BETS!So hard to say....so many are going to want to get in on this given the quarterly financials, but the short squeeze is going to be the initial driver that will sky rocket this on open as they race to cover. Profit takers and day traders will slow the climb, but the fact is this is an easy 5 bagger and it is not worth the risk to try and time the dips. Just sit back for a month...there will be an uplist and at that point we will really fly!!! My guess is a 125% close. Seems crazy but with revenue like tilray it would be stupid not to invest here. Shorters - go short tilray to make your money back! Wish I had more invested right now :(
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities